AT
Alveo is a pre-clinical stage medical diagnostics company focused on developing novel biomarker assays for early disease detection. Their technology aims to improve diagnostic accuracy and speed, addressing the critical need for timely interventions in patient care.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Alveo is a pre-clinical stage medical diagnostics company focused on developing novel biomarker assays for early disease detection. Their technology aims to improve diagnostic accuracy and speed, addressing the critical need for timely interventions in patient care.